Verrica Pharmaceuticals Inc. (VRCA) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 322 transactions totaling $88.8M, demonstrating a bullish sentiment with $72.4M in net insider flow. The most recent transaction on Dec 23, 2025 involved a transaction of 10,000 shares valued at $0.
No significant insider buying has been recorded for VRCA in the recent period.
No significant insider selling has been recorded for VRCA in the recent period.
Based on recent SEC filings, insider sentiment for VRCA is bullish with an Insider Alignment Score of 91/100 and a net flow of $72.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Verrica Pharmaceuticals Inc. (VRCA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading VRCA stock, having executed 322 transactions in the past 90 days. The most active insider is Paul B. Manning (Executive), who has made 43 transactions totaling $48.0M.
Get notified when executives and directors at VRCA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | J. Kirby John | Executive | Award | 10,000 | $N/A | $0 | |
| Nov 25, 2025 | B. Manning Paul | Executive | Purchase | 2,750,762 | $4.24 | $11.7M | Large |
| Nov 25, 2025 | B. Manning Paul | Executive | Purchase | 1,375,380 | $4.24 | $5.8M | Large |
| Nov 25, 2025 | Rieger Jayson | Executive | Purchase | 94,311 | $4.24 | $399.9K | |
| Nov 25, 2025 | Zawitz David | Executive | Purchase | 10,000 | $4.24 | $42.4K | |
| Nov 25, 2025 | J. Kirby John | Executive | Purchase | 3,536 | $4.24 | $15.0K | |
| Nov 25, 2025 | L. Rosenberg Noah | Executive | Purchase | 2,357 | $4.24 | $10.0K | |
| Sep 19, 2024 | B. Manning Paul | Executive | Gift | 2,675,611.25 | $N/A | $0 | |
| Sep 19, 2024 | B. Manning Paul | Executive | Gift | 891,870.41 | $N/A | $0 | |
| Sep 19, 2024 | B. Manning Paul | Executive | Gift | 891,870.42 | $N/A | $0 | |
| Sep 19, 2024 | B. Manning Paul | Executive | Gift | 891,870.42 | $N/A | $0 | |
| Aug 27, 2024 | White Ted | Executive | Sale | 9,021 | $2.46 | $22.2K | |
| Aug 27, 2024 | Kohler Terry | Executive | Sale | 7,899 | $2.46 | $19.4K | |
| Aug 27, 2024 | Bonaccorso Joe | Executive | Sale | 8,993 | $2.46 | $22.1K | |
| Aug 27, 2024 | Goldenberg Gary | Executive | Sale | 3,601 | $2.46 | $8.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 75 | $80.6M | 90.8% |
Sale(S) | 217 | $8.2M | 9.2% |
Award(A) | 15 | $0 | 0.0% |
Gift(G) | 8 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insiders at Verrica Pharmaceuticals Inc. are accumulating shares at an accelerated pace. With 21 insiders making 322 transactions totaling $80.6M in purchases versus $8.2M in sales, the net buying activity of $72.4M signals strong executive confidence. Paul B. Manning (Executive) leads the buying activity with $48.0M in transactions across all time.